Full-Time

Regional Director of Pharmacy

Multiple Teams

Posted on 9/25/2025

Mixlab

Mixlab

51-200 employees

Veterinary pharmacy creating customized pet medications

Compensation Overview

$185k - $195k/yr

Los Angeles, CA, USA

In Person

Travel required (up to 25%) to pharmacy sites across the U.S.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Data Analysis
Requirements
  • Active Pharmacist license in California; ability to obtain others as needed. Multiple state licenses preferred.
  • 5+ years of experience in pharmacy operations, with at least 2 years in multi-site leadership roles.
  • Deep knowledge of non-sterile compounding and regulatory requirements (USP 795/800).
  • Proven track record managing quality and compliance across pharmacy operations.
  • Experience leading diverse, distributed teams with 30+ FTEs.
  • Strong communication skills and ability to influence across levels and functions.
  • Highly organized, data-driven, and comfortable in a fast-paced, rapidly changing environment.
  • Travel required (up to 25%) to pharmacy sites across the U.S.
Responsibilities
  • Work alongside the executive team to hone efficiencies, elevate production and uphold operational standards including performance metrics, safety, and compliance.
  • Provide direct leadership and oversight of pharmacy operations across both the NY and FL labs.
  • Serve as the PIC for one site (CA) while supervising the designated PICs at Mixlab WI and Mixlab TX.
  • Supervise and support the growth of on-site pharmacists and pharmacy technicians across CA, TX and WI labs.
  • Ensure consistent operational standards, SOP implementation, and performance metrics across both sites.
  • Collaborate closely with site-level pharmacists, technicians, and corporate teams to drive improvements and efficiencies.
  • Work with logistics, supply chain, care, compliance, and engineering teams to ensure seamless end-to-end operations.
  • Own and drive KPIs including but not limited to: Prescription turnaround time: Target new scripts < 1 day, refills, < 2.5 days; Order accuracy rate: Maintain ≥99.9% across both sites; Inventory accuracy: ≥98% via monthly reconciliation audits; Labor efficiency: Script per FTE > as defined by quarterly goals; Daily Site Script and revenue goal: 100%; On-time delivery rates: 92%+ for standard and expedited shipping.
  • Monitor and analyze production workflows to identify and resolve process inefficiencies.
  • Develop and implement capacity planning tools, shift scheduling optimizations, and technician utilization models to meet demand.
  • Process, compound, and review medication orders as needed.
  • Act as the designated person for compounding for CA Site per USP <795> defined as follows: Compounded nonsterile preparations: The responsibility of the designated person(s) includes but is not limited to: Overseeing a training program to ensure competency of personnel: Personnel with direct oversight. Cleaning personnel. Personnel that compound CNSPs. Personnel that perform in-process checks. Personnel that perform final verification. Personnel that dispensing CNSPs. Certifiers/contractors/inspectors/surveyors. *Designated person can delegate training to an assigned trainer. Selecting an acceptable and reliable source to obtain non-active pharmaceutical ingredients (API) components when they are not available via an FDA-registered facility. Monitoring and observing compounding activities and taking immediate corrective action if deficient practices are observed. This includes evaluating when individuals should be excluded from working in compounding areas, which is based on the risk of contaminating the CNSP and the environment. Ensuring that policies and procedures are fully implemented. Making or approving any change(s) or alternations(s) to policy and procedure. Reviewing and approving all policies and procedures initially and at least every 12 months to ensure they reflect current practices. Ensure that follow-up is carried out if problems, deviations, or errors are identified. Have a process that allows for special accommodation for personnel if the quality of the CNSP is maintained and the environment will not be affected. Ensure there is an area designated for nonsterile compounding. Ensure that the organization has a formal, written quality assurance (QA) and quality control (QC) program. Have training, experience, responsibility, and authority in quality assurance. Reviews and documents the QA and QC program at least every 12 months. Reviews all complaints to determine whether the complaint indicates a potential quality problem with the CNSP. Determines whether a CNSP is expected to retain its integrity or quality when temperature excursions occur when compared to USP <659>.
  • Act as the Performance Improvement Coordinator for CA site:
  • Assist with the compounding of non-sterile pharmaceutical preparations
  • Maintain knowledge of and follow applicable SOPs, USP chapters <795>, <800>, and all relevant chapters and regulatory standards
  • Ensure collection of quality related data (e.g. internal/external variances, compound potency, chemical purity)
  • Participate in Performance Improvement (PI) activities, internal audits, training documentation, and variance analysis
  • Participate in preparation of the Annual PI Report with the Compliance team
  • Report ADRS, internal quality concerns, etc. to applicable agency
  • Conduct and complete documentation on annual reassessments
  • Conduct CQI activities in conjunction with the VP of and OPS and Compliance
  • Develop the leadership teams at each respective team to deliver on our core values of make it happen, do what’s right, and mix with love. This entails helping them coach their employees, leading process improvement projects, and thinking big picture on who we can ensure Mixlab provides superior service
  • Prepare site teams for the next level of managers for each respective function - processing and compounding
  • Collaborate with the digital and AI team to provide guidance on product features
  • Communicate with Veterinarians and their staff and Pet Parents as required.
Desired Qualifications
  • Experience in veterinary pharmacy or startup/high-growth environments.
  • Multi-State Licensure.
  • Prior success navigating NABP, state inspections, or DEA audits.
  • Familiarity with pharmacy software platforms and workflow automation tools.

Mixlab partners with veterinarians to create and deliver customized medications for pets. It uses a digital platform that veterinarians use to write and manage prescriptions, replacing faxes and phone calls, and then ships compounded and branded medications directly to pet owners’ homes. The product works by customizing dosage, form (liquids, treats, transdermal gels), and flavor (over 30 options) to improve pet compliance, alongside offering generic and brand-name meds and OTC products. Mixlab differentiates itself through veterinary collaboration, a focus on pet-specific compounding, a streamlined e-prescribing workflow, fast delivery (free next-day shipping nationwide and same-day delivery in major metros), and strategic acquisitions like NexGen Animal Health to extend services to large animals. Its goal is to simplify pet medication management for veterinarians and pet owners while expanding access to diverse, palatable, and timely treatments.

Company Size

51-200

Company Stage

Series A

Total Funding

$40.5M

Headquarters

New York City, New York

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Instinct integration shows sustained week-over-week adoption in specialty and emergency hospitals since late 2025.
  • Large animal market expansion unlocks new revenue streams from underserved equine and exotic practitioners.
  • AVMA partnership validation accelerates practice adoption through professional endorsements and regulatory credibility.

What critics are saying

  • Amazon Pharmacy and Chewy's compounding labs eliminate Mixlab's delivery and convenience moat by 2027.
  • FDA enforcement on non-PCAB compounders forces compliance cost spikes or service restrictions.
  • Single contamination or dosing error triggers class-action litigation and veterinary trust collapse.

What makes Mixlab unique

  • AI-powered eMix platform embeds pharmacy workflows directly into veterinary practice management software.
  • Same-day and next-day delivery across all 50 states with 30+ medication flavors.
  • Expanded to large animals via NexGen acquisition, serving equine, exotic, and zoo practitioners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Sick Leave

Company Stock Options

Health Savings Account/Flexible Spending Account

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

4%

2 year growth

0%
BizTimes
Jan 15th, 2025
The Pet Apothecary in Glendale acquired by New York-based veterinary pharmacy

New York-based veterinary pharmacy Mixlab has acquired Glendale-based pet pharmacy The Pet Apothecary and the veterinary business of Ohio-based SBH

Business Wire
May 23rd, 2024
Mixlab Expands Veterinary Compounding Offering into Large Animals with the Acquisition of NexGen Animal Health

Mixlab, the leading modern veterinary pharmacy, has acquired NexGen Animal Health, expanding its compounding services to also serve large animals.

Business Wire
May 22nd, 2024
Mixlab Acquires NexGen, Expands to Large Animals

Mixlab, a leading veterinary pharmacy, has acquired NexGen Animal Health to expand its compounding services to large animals, including equine, exotic, wildlife, and zoo animals. With financial backing from Vanterra Ventures, Mixlab will leverage its technology platform to enhance pharmacy experiences and increase production efficiency. The acquisition adds a fourth pharmacy in Texas, complementing existing locations in NY, CA, and FL, and aims to meet rising demand with improved customer care and delivery times.

Business Wire
Aug 15th, 2023
Mixlab Raises $10M to Enhance its Best-in-Class Veterinary Pharmacy Platform and Expand Operations Nationwide

Mixlab, the veterinarian-partnered pharmacy, raises $10M led by Vanterra Ventures, with participation from Lakehouse Ventures and others.

TechCrunch
Aug 14th, 2023
Mixlab adds to veterinary pharmacy footprint following $10M Series A extension | TechCrunch

Today, Mixlab announced $10 million in additional funding to meet some of the demand of veterinary services.

INACTIVE